Funding Opportunities

NIH Funding Opportunities

Notice to Correct the Last Advisory Council Review and Last Earliest Start Dates for NIDDK PAR-15-171 "Diet and Physical Activity Assessment Methodology (R21)"
Notice NOT-DK-15-012 from the NIH Guide for Grants and Contracts
Fri, 24 Apr 2015 12:48:42 EST

Notice to Correct the Last Advisory Council Review and Last Earliest Start Dates for NIDDK PAR-15-170 "Diet and Physical Activity Assessment Methodology (R01)"
Notice NOT-DK-15-013 from the NIH Guide for Grants and Contracts
Fri, 24 Apr 2015 12:45:30 EST

Change in Application Due Dates for PAR-14-023 "Pre-application for a Biomedical Technology Research Resource (X02)"
Notice NOT-GM-15-115 from the NIH Guide for Grants and Contracts
Fri, 24 Apr 2015 12:12:45 EST

NHLBI No Longer Participates in PAR-13-137 "Bioengineering Research Grants (BRG) (R01)"
Notice NOT-HL-15-259 from the NIH Guide for Grants and Contracts
Wed, 22 Apr 2015 09:52:51 EST

NHLBI Announces Final Receipt Dates for Requests to the DNA Resequencing and Genotyping Service
Notice NOT-HL-15-260 from the NIH Guide for Grants and Contracts
Fri, 24 Apr 2015 12:17:20 EST

Notice of Correction Regarding Funding Opportunity RFA-MH-16-200 "Methodologies to Enhance Understanding of HIV- Associated Social Determinants"
Notice NOT-MH-15-015 from the NIH Guide for Grants and Contracts
Mon, 20 Apr 2015 02:50:50 EST

Notice of Correction Regarding Companion Funding Opportunity RFA-MH-16-205 "Methodologies to Enhance Understanding of HIV- Associated Social Determinants"
Notice NOT-MH-15-017 from the NIH Guide for Grants and Contracts
Mon, 20 Apr 2015 03:43:51 EST

Notice to Expire RFA-MH-16-405 "Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R21/R33)"
Notice NOT-MH-15-018 from the NIH Guide for Grants and Contracts
Thu, 23 Apr 2015 01:19:59 EST

Notice of Multiple Changes to PA-15-122 "Administrative Supplements for Common Basic Sociobehavioral Mechanisms and Processes that Facilitate or Impede Self-Management of Chronic Conditions (Admin Supp)"
Notice NOT-OD-15-094 from the NIH Guide for Grants and Contracts
Thu, 23 Apr 2015 01:07:09 EST

Request for Information: NIH Precision Medicine Cohort
Notice NOT-OD-15-096 from the NIH Guide for Grants and Contracts
Mon, 20 Apr 2015 04:05:43 EST

Characterization of Pro- and Anti-Geronic Proteins and Peptides (R01)
Funding Opportunity RFA-AG-16-005 from the NIH Guide for Grants and Contracts. The goal of this FOA is to advance research on naturally occurring proteins (and/or peptides) known to impact one or more aging phenotypes, at physiological levels, based on whole-animal experimental evidence. These are "geronic proteins" isolated from circulation, which might reverse (rejuvenate) or potentially prevent development of aging phenotypes observable in an older laboratory animal, such as cardiac hypertrophy, diminished skeletal muscle repair-efficiency, reduced muscle strength, etc. (anti-geronic proteins), or which appear to promote an aging phenotype in a young adult laboratory animal, such as leading to decreased neurogenesis or cognitive function (pro-geronic proteins). (For brevity, this definition includes "geronic peptides.") The pro- or anti-geronic functions of these proteins have been demonstrated to have physiological consequences at least at the level of tissue or organ function, but often have additional support for their geronic functions at the cellular and molecular levels (but, importantly, in whole-animal experiments). These anti- and pro-geronic proteins are often known to function in other biological contexts, such as development. The primary goals of this FOA are to characterize the geronic functions of these proteins. The outcome of research supported by this FOA should be an improved understanding of the range of aging phenotypes affected by geronic proteins (individually or in concert), the cellular and molecular mechanisms by which these geronic functions are exerted, and will eventually promote studies supporting the translational potential of these proteins.
Thu, 23 Apr 2015 12:46:50 EST

Innovation for HIV Vaccine Discovery (R01)
Funding Opportunity RFA-AI-15-019 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications proposing innovative, high risk, high impact research to identify novel HIV vaccine concepts and targets. A further focus is to answer important scientific questions that will aid in the design and development of an effective immunogen that may provide long-term safe protection from either acquisition of or ongoing infection by HIV. Thus, this FOA aims to support early discovery research by supporting the testing of novel hypotheses and approaches, and to reward initial success with continued funding that is dependent upon achieving applicant-proposed and pre-award negotiated Go/No-Go criteria by the year-2 progress report.
Mon, 20 Apr 2015 06:35:46 EST

NIH-PEPFAR Collaboration on Implementation Science for HIV: Towards an AIDS-free Generation (R01)
Funding Opportunity RFA-AI-15-020 from the NIH Guide for Grants and Contracts. The NIH, in collaboration with the Office of the Global AIDS Coordinator (OGAC) is soliciting applications for implementation science research that will inform delivery and scale-up of efficacious interventions to improve HIV prevention, care, and treatment in Africa.
Fri, 24 Apr 2015 12:40:37 EST

NIH-PEPFAR Collaboration on Implementation Science for HIV: Towards an AIDS-free Generation (R21)
Funding Opportunity RFA-AI-15-021 from the NIH Guide for Grants and Contracts. The NIH, in collaboration with the Office of the Global AIDS Coordinator (OGAC) is soliciting applications for implementation science research that will inform delivery and scale-up of efficacious interventions to improve HIV prevention, care, and treatment in Africa.
Fri, 24 Apr 2015 12:40:36 EST

Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12)
Funding Opportunity RFA-DK-15-006 from the NIH Guide for Grants and Contracts. To foster the development of a diverse and highly trained workforce of pediatric endocrinologists to assume leadership roles related to the Nations biomedical and behavioral research efforts in the area of pediatric diabetes, This Funding Opportunity Announcement (FOA) invites applications for institutional career development programs in diabetes research for pediatric endocrinologists. The NIDDK will award physician scientist career development program (K12) grants to eligible institutions to provide a program to prepare pediatricians, selected by the institution, for careers in pediatric endocrinology research related to diabetes.
Tue, 21 Apr 2015 11:33:37 EST

Postdoctoral Research Training in Pediatric Clinical Pharmacology and Therapeutics (T32)
Funding Opportunity RFA-HD-16-015 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites grant applications from institutions/organizations that propose to develop clinician-scientists who will be leaders in the field of pediatric clinical pharmacology research. Individuals in these programs should receive training and experience in the methods and conduct of basic and clinical research, in order to qualify them to perform such studies independently.
Mon, 20 Apr 2015 03:17:50 EST

Technologies for Improving Population Health and Eliminating Health Disparities (R41/R42)
Funding Opportunity RFA-MD-15-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to developa product, process or service for commercialization with the aim of reducing disparities in healthcare access and health outcomes.Appropriate technologies should be effective, affordable, culturally acceptable, and deliverable to racial/ethnic minorities, low-income and rural populations.
Fri, 24 Apr 2015 12:00:41 EST

Innovations for Healthy Living - Improving Population Health and Eliminating Health Disparities (R43)/(R44)
Funding Opportunity RFA-MD-15-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to developa product, process or service for commercialization with the aim of reducing disparities in healthcare access and health outcomes and in preventing disease and improving health. Appropriate technologies should be effective, affordable, culturally acceptable, and deliverable to racial/ethnic minorities, low-income and rural populations.
Fri, 24 Apr 2015 12:58:32 EST

Tobacco Regulatory Science Small Grant Program for New Investigators (R03)
Funding Opportunity RFA-OD-15-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support New Investigators in the biomedical, behavioral, and social sciences who are in the early stages of establishing independent careers in tobacco regulatory research.The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.Applicants are encouraged to conduct projects that ultimately have potential to inform regulations on tobacco product manufacturing, distribution, and marketing.Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31.
Thu, 23 Apr 2015 12:38:39 EST